Navigation Links
Psoriatic arthritis patients need better screening, warns panel of experts
Date:7/23/2014

Leading experts have joined together for the first time to call for better screening of psoriatic arthritis to help millions of people worldwide suffering from the condition.

Psoriatic arthritis (PsA) causes painful joint inflammation and can cause irreversible joint damage if left untreated.

PsA tends to affect people with the skin condition psoriasis, which causes a red, scaly rash, and affects approximately two per cent of people in the UK.

Around one in five go on to develop PsA usually within ten years of the initial skin problem being diagnosed.

Coming together to tackle the gaps in the treatment and diagnosis of psoriatic arthritis, expert rheumatologists, dermatologists and patient representatives from Europe and North America formed the Psoriatic Arthritis Forum, and have now made a series of recommendations to combat the condition.

The recommendations were published the journal Arthritis Care and Research.

They included:

  • Developing a screening tool for dermatologists and primary care doctors to identify suspected PsA patients
  • Raising awareness about the progression, health-related quality of life components, and other health issues associated with PsA
  • Improving communication between healthcare providers and patients

Dr Philip Helliwell, of the School of Medicine at the University of Leeds, a member of the Psoriatic Arthritis Forum, said:

"We believe up to 50% of psoriasis patients with psoriatic arthritis are undiagnosed, living with sore, stiff and tender joints, without understanding what is causing this pain. Our review points the way forward for effective screening and treatment, in the hope that detection rates of the condition are improved and patients enjoy a better quality of life."

In addition to better screening, experts have called for improved referrals of patients, as well as an algorithm a step-by-step procedure for primary care physicians - to be developed to help community physicians on patient evaluation and treatment decisions.

Dr Helliwell added: "These recommendations serve as a guide for improving the timely diagnosis of PsA, as well as promoting global awareness of PsA. We need to develop better screening tools as a matter of urgency, as these will be cost-effective and lead to better health outcomes for thousands of people."


'/>"/>
Contact: Ben Jones
B.P.Jones@leeds.ac.uk
44-011-334-38059
University of Leeds
Source:Eurekalert

Related medicine news :

1. Long-term apremilast demonstrates continued efficacy in patients with psoriatic arthritis
2. Brodalumab demonstrates significant clinical response in psoriatic arthritis
3. New STELARA data show inhibition of joint destruction in active psoriatic arthritis
4. Aggressive treatment of psoriatic arthritis results in significant improvement, says new research
5. One-third of psoriatic arthritis patients are not receiving optimal dosing of adalimumab
6. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
7. Treat Rheumatoid Arthritis Early and Aggressively: Guidelines
8. Gastro Woes Often Strike Rheumatoid Arthritis Patients
9. Mayo Clinic: Obesity epidemic fueling rise in rheumatoid arthritis among women
10. One-third of adult Americans with arthritis battle anxiety or depression
11. Children with juvenile arthritis have higher rates of bacterial infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... , the only authorized OSHA Training Institute Education Center headquartered in Northern California, ... their workers from extreme heat at their worksites. Employers with workers exposed ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Cut Pro X users can now reveal the media of their split screens ...
(Date:6/27/2016)... ... 2016 , ... TherapySites, the leading website and ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to extend ... exclusive benefits and promotional offers. , "TCA is extremely excited about this new ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/27/2016)... ... 27, 2016 , ... A revolution is underway. Brooklyn-based ... experience for the millions of people who require these medical transport services annually. ... through the use of technology. Now, SmartEMS has put forth an industry-changing app ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: